- Home
- ASRT vs ATRA Comparison
ASRT vs ATRA Comparison
Compare ASRT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ATRA
- Stock Information
- Founded
- ASRT 1995
- ATRA 2012
- Country
- ASRT United States
- ATRA United States
- Employees
- ASRT N/A
- ATRA N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRT Health Care
- ATRA Health Care
- Exchange
- ASRT Nasdaq
- ATRA Nasdaq
- Market Cap
- ASRT 57.9M
- ATRA 51.1M
- IPO Year
- ASRT 1997
- ATRA 2014
- Fundamental
- Price
- ASRT $0.74
- ATRA $11.58
- Analyst Decision
- ASRT Strong Buy
- ATRA Strong Buy
- Analyst Count
- ASRT 2
- ATRA 4
- Target Price
- ASRT $3.25
- ATRA $20.00
- AVG Volume (30 Days)
- ASRT 244.1K
- ATRA 60.7K
- Earning Date
- ASRT 08-06-2025
- ATRA 08-11-2025
- Dividend Yield
- ASRT N/A
- ATRA N/A
- EPS Growth
- ASRT N/A
- ATRA N/A
- EPS
- ASRT N/A
- ATRA N/A
- Revenue
- ASRT $119,001,000.00
- ATRA $199,732,000.00
- Revenue This Year
- ASRT N/A
- ATRA N/A
- Revenue Next Year
- ASRT $11.91
- ATRA N/A
- P/E Ratio
- ASRT N/A
- ATRA N/A
- Revenue Growth
- ASRT N/A
- ATRA 475.53
- 52 Week Low
- ASRT $0.51
- ATRA $5.01
- 52 Week High
- ASRT $1.58
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- ASRT 61.81
- ATRA 66.87
- Support Level
- ASRT $0.66
- ATRA $8.53
- Resistance Level
- ASRT $0.79
- ATRA $13.46
- Average True Range (ATR)
- ASRT 0.04
- ATRA 0.96
- MACD
- ASRT 0.01
- ATRA 0.28
- Stochastic Oscillator
- ASRT 64.29
- ATRA 62.65
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).